Champions Oncology (NASDAQ:CSBR) will be issuing its quarterly earnings data after the market closes on Thursday, December 7th.

Champions Oncology (NASDAQ:CSBR) last announced its quarterly earnings results on Thursday, September 14th. The biotechnology company reported ($0.06) EPS for the quarter. Champions Oncology had a negative return on equity of 338.01% and a negative net margin of 29.87%. The company had revenue of $5.03 million for the quarter.

Shares of Champions Oncology (NASDAQ:CSBR) opened at $3.50 on Thursday. Champions Oncology has a one year low of $1.89 and a one year high of $4.79.

COPYRIGHT VIOLATION WARNING: This story was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at

About Champions Oncology

Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.

Earnings History for Champions Oncology (NASDAQ:CSBR)

Receive News & Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related companies with's FREE daily email newsletter.